An Open-Label, 2-Part Sequential Dose Study Designed to Assess the Absolute Bioavailability, Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1404 Administered to Healthy Male Subjects

Trial Profile

An Open-Label, 2-Part Sequential Dose Study Designed to Assess the Absolute Bioavailability, Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1404 Administered to Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Oct 2016

At a glance

  • Drugs SK 1404 (Primary) ; SK 1404 (Primary)
  • Indications Nocturia
  • Focus Pharmacokinetics
  • Sponsors Sanwa Kagaku Kenkyusho
  • Most Recent Events

    • 12 Oct 2016 Status changed from recruiting to completed.
    • 07 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top